The possible role of postoperative azotemia in enhanced survival of patients with metastatic renal cancer after cytoreductive nephrectomy.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cancer Research

• Publication date

  2002-09-15

• Fields of study

  Medicine

• Identifiers
  PMID 12234987
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic acidosis.

  2004cited by this paper
• The effects of extracellular pH on immune function

  2001cited by this paper
• Back to nephrectomy for patients with metastatic renal cancer.

  2001cited by this paper
• Back to nephrectomy for patients with metastatic renal cancer

  2001cited by this paper
• Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

  2001cited by this paper
• Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

  2001cited by this paper
• A cellular automaton model of early tumor growth and invasion.

  2001cited by this paper
• Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells

  2001cited by this paper
• A Cellular Automaton Model of Early Tumor Growth and Invasion: The Effects of Native Tissue Vascularity and Increased Anaerobic Tumor Metabolism

  2001influential reference
• Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy.

  2000cited by this paper
• Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells.

  2000cited by this paper
• Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.

  1999cited by this paper
• An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis

  1999cited by this paper
• Acidic environment causes apoptosis by increasing caspase activity

  1999cited by this paper
• Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group.

  1998cited by this paper
• A reaction-diffusion model of cancer invasion.

  1996cited by this paper
• Regression of metastatic renal cell carcinoma after cytoreductive nephrectomy.

  1993cited by this paper
• Williams Textbook of Endocrinology

  1987cited by this paper
• The Systemic consequences of renal failure

  1984cited by this paper
• Effects of systemic acidification of mice with Sarcoma 180.

  1979cited by this paper
• Serum electrolyte and acid base composition. The influence of graded degrees of chronic renal failure.

  1979cited by this paper
• The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma.

  1977cited by this paper
• Tumor growth inhibition by ammonium chloride-induced acidosis.

  1975cited by this paper
• Spontaneous Regression of Cancer: preliminary Report

  1956cited by this paper
• Spontaneous regression of cancer: preliminary report.

  1956cited by this paper
• Inhibition of experimental production of liver cancer by addition of acetic acid to the diet.

  1953cited by this paper

• PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor–based First-line Therapy in Metastatic Renal Cell Carcinoma Patients

  2024cites this paper
• Mathematical and Machine Learning Models of Renal Cell Carcinoma: A Review

  2023cites this paper
• The role of cytoreductive nephrectomy in the treatment of patients with metastatic kidney cancer – review article

  2023cites this paper
• Shifting role of cytoreductive nephrectomy according to type of systemic therapy: A nationwide cohort study.

  2022cites this paper
• Cytoreductive nephrectomy: identifying an ideal candidate based on preoperative predictive factors

  2022cites this paper
• Surgical management in metastatic renal cell carcinoma.

  2022cites this paper
• Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature

  2021cites this paper
• Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status—results from a Finnish nation-wide population-based study from 2005 to 2010

  2021cites this paper
• Long-Term Survival Outcomes of Cytoreductive Nephrectomy Combined with Targeted Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Individual Patient Data Meta-Analysis

  2021cites this paper
• The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors

  2020cites this paper
• Redefining the Role of Surgical Management of Metastatic Renal Cell Carcinoma

  2020cites this paper
• Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?

  2019cites this paper
• Cytoreductive nephrectomy in the current treatment algorithm

  2019cites this paper
• Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates?

  2019cites this paper
• Cytoreductive nephrectomy in metastatic kidney cancer: what do we do now?

  2019cites this paper
• Re: Comparison of immediate vs. deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial

  2019cites this paper
• Indications, complications, and outcomes following surgical management of locally advanced and metastatic renal cell carcinoma

  2018cites this paper
• Cytoreductive Nephrectomy and Metastasectomy for Renal Cell Carcinoma

  2018cites this paper
• Cytoreductive nephrectomy in the era of targeted therapies: a review

  2017cites this paper
• Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma.

  2017cites this paper
• The Evolving Role of Cytoreductive Surgery for Metastatic Renal Cell Carcinoma

  2017cites this paper
• Sunitinib in Special Situations in their Daily Practice

  2016cites this paper
• Prognostic value of cytoreductive nephrectomy combined with targeted therapy for metastatic renal cell carcinoma: a meta-analysis

  2016cites this paper
• Tratamiento del cáncer de riñón metastásico

  2015cites this paper
• Surgical considerations for patients with metastatic renal cell carcinoma.

  2015cites this paper
• Cytoreductive nephrectomy: past, present and future

  2014cites this paper
• Prise en charge du cancer du rein métastatique

  2014cites this paper
• Understanding cancer mechanisms through network dynamics 545

  2012cites this paper
• Understanding cancer mechanisms through network dynamics.

  2012cites this paper
• Metastasiertes Nierenzellkarzinom

  2011cites this paper
• The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy.

  2011cites this paper
• [Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: a literature review].

  2010cites this paper
• [Is the cytoreductive nephrectomy still necessary in case of metastases?].

  2010cites this paper
• Role of surgery in advanced/metastatic renal cell carcinoma

  2010cites this paper
• Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: focus on special populations

  2010cites this paper
• Place de la chirurgie (néphrectomie cytoréductrice et métastasectomie) dans la prise en charge du cancer du rein métastatique : revue de la littérature

  2010cites this paper
• La néphrectomie est-elle indispensable en cas de métastases ?

  2010cites this paper
• Metastatic renal cell carcinoma: many treatment options, one patient.

  2009cites this paper
• Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy

  2009cites this paper
• Proton transport inhibitors as potentially selective anticancer drugs.

  2009cites this paper
• The role of cytoreductive nephrectomy in the era of molecular targeted therapy

  2009cites this paper
• Advanced Disease: Nonpulmonary Metastases

  2008cites this paper
• Nephrectomy in Patients with Metastatic Renal Cell Carcinoma: Clinical and Biologic Effects

  2008cites this paper
• Current status of debulking nephrectomy in the era of tyrosine kinase inhibitors

  2008influential citation
• Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: Is It Still Imperative in the Era of Targeted Therapy?

  2007cites this paper
• Glycolysis in cancer: a potential target for therapy.

  2007cites this paper
• Metabolic changes during carcinogenesis: potential impact on invasiveness.

  2007cites this paper
• The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy.

  2007cites this paper
• Acid-mediated tumor invasion: a multidisciplinary study.

  2006cites this paper
• Molecularly targeted therapy in renal cell carcinoma: where do we go from here?

  2006cites this paper
• The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature.

  2005cites this paper
• The role of acidity in solid tumour growth and invasion.

  2005cites this paper
• Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

  2005cites this paper
• Re: Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

  2005cites this paper
• The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis

  2005cites this paper
• Debulking Nephrectomy in Metastatic Renal Cancer

  2004cites this paper
• Why do cancers have high aerobic glycolysis?

  2004cites this paper
• The Timing of Immunotherapy and Nephrectomy in Multimodality Treatment of Metastatic Renal Cell Carcinoma

  2003cites this paper
• The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.

  2003cites this paper
• Microenvironmental and cellular consequences of altered blood flow in tumours.

  2003cites this paper